Vanguard Portfolio Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.4B Sell
6,214,356
-141,721
-2% -$52.6M 0.11% 196
2026
Q1
$1.86B Buy
+6,356,077
New +$2.09B 0.1% 237

Other funds holding ELV

Vanguard Portfolio Management's ELV Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Elevance Health (ELV) stake by 2.2% in Q2 2026, selling an estimated $52.6M and leaving 6,214,356 shares worth $2.4B. The position accounts for 0.11% of the portfolio, ranked #196.

Vanguard Portfolio Management first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vanguard Portfolio Management held 6,214,356 shares of Elevance Health worth $2.4B as of Q2 2026.
  • Vanguard Portfolio Management sold 141,721 Elevance Health shares in Q2 2026, an estimated $52.6M.
  • Elevance Health made up 0.11% of Vanguard Portfolio Management's portfolio in Q2 2026, its #196 holding.
  • Vanguard Portfolio Management first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.